标题
IL-1 Family Members in Cancer; Two Sides to Every Story
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-06-07
DOI
10.3389/fimmu.2019.01197
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells
- (2019) Locke D. Uppendahl et al. GYNECOLOGIC ONCOLOGY
- Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer
- (2019) Oxana Dmitrieva-Posocco et al. IMMUNITY
- Role for nuclear interleukin-37 in the suppression of innate immunity
- (2019) Suzhao Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
- (2018) Kyohei Nakamura et al. CANCER CELL
- HER2 Overexpression Triggers an IL1α Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance
- (2018) Shou Liu et al. CANCER RESEARCH
- IL-1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer
- (2018) Te-Chia Wu et al. CANCER RESEARCH
- A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33
- (2018) Liang Ding et al. CARCINOGENESIS
- The enigmatic role of IL-38 in inflammatory diseases
- (2018) Thomas Garraud et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A tumor–myeloid cell axis, mediated via the cytokines IL-1α and TSLP, promotes the progression of breast cancer
- (2018) Emma L. Kuan et al. NATURE IMMUNOLOGY
- Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells
- (2018) Zhiping Yang et al. OncoTargets and Therapy
- Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases
- (2018) Graeme P. Sullivan et al. Cell Death & Disease
- IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway
- (2018) Mingfang Jiang et al. Thoracic Cancer
- An Interleukin-1 Signature in Breast Cancer Treated with Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors
- (2018) Charles Anthony Dinarello CANCER RESEARCH
- Interleukin-1 Beta—A Friend or Foe in Malignancies?
- (2018) Rebekka Bent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of IL-33/ST2 Pathway in Tumorigenesis
- (2018) Kristen Larsen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2
- (2018) Yongkui Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization
- (2018) Zafira Castaño et al. NATURE CELL BIOLOGY
- Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
- (2018) Hiroaki Takatori et al. Frontiers in Immunology
- Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer
- (2018) Aliyah M. Weinstein et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis
- (2018) Yichao Chen et al. Nanomedicine-Nanotechnology Biology and Medicine
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression
- (2018) Feng Wang et al. Open Biology
- Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer
- (2018) Razelle Kurzrock et al. OncoImmunology
- IL-1 and IL-1 regulatory pathways in cancer progression and therapy
- (2017) Alberto Mantovani et al. IMMUNOLOGICAL REVIEWS
- Biology of IL-38 and its role in disease
- (2017) Frank L. van de Veerdonk et al. IMMUNOLOGICAL REVIEWS
- Regulation and function of interleukin-36 cytokines
- (2017) Esen Yonca Bassoy et al. IMMUNOLOGICAL REVIEWS
- Suppression of inflammation and acquired immunity by IL-37
- (2017) Giulio Cavalli et al. IMMUNOLOGICAL REVIEWS
- S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
- (2017) Benjamin Weichand et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation
- (2017) Y Li et al. ONCOGENE
- Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells
- (2017) C Luo et al. ONCOGENE
- Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression
- (2017) Kazuki Takada et al. PLoS One
- Cancer cells induce interleukin-22 production from memory CD4+T cells via interleukin-1 to promote tumor growth
- (2017) Cornelia Voigt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wounds that heal and wounds that don’t − The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis
- (2017) Neal L. Millar et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- IL-36α suppresses proliferation of ovarian cancer cells
- (2017) Lei Chang et al. TUMOR BIOLOGY
- Propiece IL-1α facilitates the growth of acute T-lymphocytic leukemia cells through the activation of NF-κB and SP1
- (2017) Yinsheng Zhang et al. Oncotarget
- Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression
- (2017) Xiaofei Yan et al. Oncotarget
- The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
- (2017) Marie-Hélène Wasmer et al. Frontiers in Immunology
- The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis
- (2017) Maryse Dagenais et al. OncoImmunology
- IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
- (2017) Valeria Lucarini et al. OncoImmunology
- Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment
- (2017) Aliyah M. Weinstein et al. OncoImmunology
- Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients
- (2016) Junwei Huo et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- IL-33 signaling fuels outgrowth and metastasis of human lung cancer
- (2016) Chunhong Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells
- (2016) Keunhee Oh et al. BMC CANCER
- Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells
- (2016) M S Islam et al. BRITISH JOURNAL OF PHARMACOLOGY
- Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
- (2016) Donye Dominguez et al. JOURNAL OF IMMUNOLOGY
- Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
- (2016) Erin A. Marshall et al. Molecular Cancer
- CCL22 and IL-37 inhibit the proliferation and epithelial-mesenchymal transition process of NSCLC A549 cells
- (2016) Yu-Hua Chen et al. ONCOLOGY REPORTS
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses
- (2016) Javier Mora et al. Journal of Molecular Cell Biology
- Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer
- (2016) M Akimoto et al. Cell Death & Disease
- Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
- (2016) Miho Akimoto et al. Nature Communications
- IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling
- (2016) Rui Liu et al. Oncotarget
- Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia
- (2016) Lei Qin et al. Oncotarget
- Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma
- (2016) Lin Lin et al. Scientific Reports
- Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
- (2016) Catherine Sautès-Fridman et al. Frontiers in Immunology
- Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
- (2016) Iryna Saranchova et al. Scientific Reports
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- IL-37 Is a Novel Proangiogenic Factor of Developmental and Pathological AngiogenesisSignificance
- (2015) Tianshu Yang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway
- (2015) Yoolhee Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
- (2015) Charlotte O'Donnell et al. BRITISH JOURNAL OF CANCER
- IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses
- (2015) Xuefeng Wang et al. CANCER CELL
- The Association of Serum IL-33 and sST2 with Breast Cancer
- (2015) Zhi-Ping Yang et al. DISEASE MARKERS
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions
- (2015) Cem Gabay et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Circulating IL-33 level is associated with the progression of lung cancer
- (2015) Myung Shin Kim et al. LUNG CANCER
- IL-37 mediates the antitumor activity in renal cell carcinoma
- (2015) Yazhuo Jiang et al. MEDICAL ONCOLOGY
- Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
- (2015) Xiaoguang Tong et al. Molecular Oncology
- IL-33 activates tumor stroma to promote intestinal polyposis
- (2015) Rebecca L. Maywald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8
- (2015) Suzhao Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma
- (2015) Xavier León et al. Oncotarget
- Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells
- (2015) Sen Wang et al. Journal of Cancer
- Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
- (2015) Ole Audun Werner Haabeth et al. OncoImmunology
- Interleukin 1α Sustains the Expression of Inflammatory Factors in Human Pancreatic Cancer Microenvironment by Targeting Cancer-Associated Fibroblasts
- (2015) Vegard Tjomsland et al. NEOPLASIA
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- IL-18 Enhances Immunosuppressive Responses by Promoting Differentiation into Monocytic Myeloid-Derived Suppressor Cells
- (2014) Hui Xuan Lim et al. JOURNAL OF IMMUNOLOGY
- Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
- (2014) Marina Fabbi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
- (2014) David S Hong et al. LANCET ONCOLOGY
- Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ
- (2014) Lei Wang et al. MEDICAL ONCOLOGY
- Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages
- (2014) Kosuke Watari et al. PLoS One
- Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells
- (2014) Jing-Jing Zhao et al. Scientific Reports
- Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma
- (2013) Qiu-Zhong Pan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
- (2013) Kun Gao et al. CANCER LETTERS
- Risk of Ovarian Cancer and the NF- B Pathway: Genetic Association with IL1A and TNFSF10
- (2013) B. Charbonneau et al. CANCER RESEARCH
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of IL-1 in the Early Tumor Cell-Induced Angiogenic Response
- (2013) Y. Carmi et al. JOURNAL OF IMMUNOLOGY
- A Dose-Escalation Study of Recombinant Human Interleukin-18 in Combination With Rituximab in Patients With Non-Hodgkin Lymphoma
- (2013) Michael J. Robertson et al. JOURNAL OF IMMUNOTHERAPY
- IL-18 Regulates Melanoma VLA-4 Integrin Activation through a Hierarchized Sequence of Inflammatory Factors
- (2013) María Valcárcel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
- (2013) Su-Feng Chen et al. JOURNAL OF PATHOLOGY
- A Role for Interleukin-1 Alpha in the 1,25 Dihydroxyvitamin D3 Response in Mammary Epithelial Cells
- (2013) Sophia L. Maund et al. PLoS One
- Interleukin-1α
- (2013) Peleg Rider et al. SEMINARS IN IMMUNOLOGY
- Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
- (2012) Caterina Musolino et al. BRITISH JOURNAL OF HAEMATOLOGY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells
- (2012) M. Terme et al. CANCER RESEARCH
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
- (2012) Jing Ni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
- (2012) Yijing Li et al. Molecular Cancer
- IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
- (2012) F. L. van de Veerdonk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Interleukin-1 Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells
- (2011) S. L. Maund et al. CANCER RESEARCH
- IL-18 Induces PD-1-Dependent Immunosuppression in Cancer
- (2011) M. Terme et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
- (2011) Ivan Jovanovic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
- (2011) I-K Choi et al. GENE THERAPY
- Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis
- (2011) J Gillibert-Duplantier et al. ONCOGENE
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
- (2011) Ole Audun Werner Haabeth et al. Nature Communications
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer cell-derived IL-1α promotes HGF secretion by stromal cells and enhances metastatic potential in pancreatic cancer cells
- (2010) Donghui Xu et al. JOURNAL OF SURGICAL ONCOLOGY
- IL-37 is a fundamental inhibitor of innate immunity
- (2010) Marcel F Nold et al. NATURE IMMUNOLOGY
- Interleukin-1 (IL-1) Pathway
- (2010) A. Weber et al. Science Signaling
- A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
- (2009) Ahmad A. Tarhini et al. CANCER
- Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44
- (2009) J. S. Kang et al. CARCINOGENESIS
- Expression of ADAM33 Is a Novel Regulatory Mechanism in IL-18-Secreted Process in Gastric Cancer
- (2009) K.-E. Kim et al. JOURNAL OF IMMUNOLOGY
- Host-Derived Interleukin-1 Is Important in Determining the Immunogenicity of 3-Methylcholantrene Tumor Cells
- (2009) M. Elkabets et al. JOURNAL OF IMMUNOLOGY
- IL-18 Paradox in Pancreatic Carcinoma: Elevated Serum Levels of Free IL-18 are Correlated With Poor Survival
- (2009) Anna Carbone et al. JOURNAL OF IMMUNOTHERAPY
- Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
- (2009) John A. Lust et al. MAYO CLINIC PROCEEDINGS
- Secreted Interleukin-1 Induces a Metastatic Phenotype in Pancreatic Cancer by Sustaining a Constitutive Activation of Nuclear Factor- B
- (2009) D. Melisi et al. MOLECULAR CANCER RESEARCH
- IL-18-producing Salmonella inhibit tumor growth
- (2008) M Loeffler et al. CANCER GENE THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started